| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |